Novusyn Research is the editorial brand behind The Peptide Intelligence Desk — an independent publication covering peptide therapeutics for researchers, clinicians, and the scientific community. We publish daily news briefs, a late-stage clinical-trials tracker, FDA/EMA regulatory coverage, pharmaceutical-company pipeline analysis, an A–Z compound directory, and long-form educational guides. We are not a pharmacy, a compounding facility, or a vendor of peptides; we sell nothing.
The desk is staffed by editors with backgrounds in life-science journalism, regulatory affairs, and clinical research methodology. Our governance, sourcing, corrections, and AI-use policies are documented on the Editorial Standards page. For tips, corrections, or editorial questions, use the contact page or write to editor@novusynresearch.com.